Mannkind (MNKD) Shares Outstanding (2010 - 2026)
Mannkind (MNKD) posted quarterly Shares Outstanding (Entity) of $308.9 million for Q1 2026, up 1.64% year-over-year from $303.9 million in Q1 2025, and little changed quarter-over-quarter from $307.8 million in Q4 2025.
Mannkind (MNKD) Shares Outstanding (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Shares Outstanding (Entity) for 17 consecutive years, with $308.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.64% year-over-year to $308.9 million; the TTM figure through Mar 2026 stood at $308.9 million (up 1.64% YoY), while the FY2025 annual figure was $307.8 million, up 1.61% from the prior year.
- Shares Outstanding (Entity) steadied at $308.9 million in Q1 2026 per MNKD's latest filing, from $307.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $308.9 million in Q1 2026 and bottomed at $252.4 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $280.3 million across 5 years, with a median of $270.8 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 1.34% — and 2025, when it gained 12.23%.
- Mannkind's Shares Outstanding (Entity) stood at $263.8 million in 2022, then advanced by 2.37% to $270.0 million in 2023, then advanced by 12.19% to $303.0 million in 2024, then grew by 1.61% to $307.8 million in 2025, then rose by 0.35% to $308.9 million in 2026.
- Business Quant data shows MNKD's Shares Outstanding (Entity) at $308.9 million in Q1 2026, $307.8 million in Q4 2025, and $306.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 309.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 309.19 Mn |
| Mar 31, 2026 | 308.27 Mn |
| Dec 31, 2025 | 305.64 Mn |
| Sep 30, 2025 | 306.81 Mn |
| Jun 30, 2025 | 304.95 Mn |
| Mar 31, 2025 | 303.48 Mn |
| Dec 31, 2024 | 274.42 Mn |
| Sep 30, 2024 | 275.00 Mn |
| Jun 30, 2024 | 273.06 Mn |
| Mar 31, 2024 | 270.36 Mn |
| Dec 31, 2023 | 267.01 Mn |
| Sep 30, 2023 | 268.73 Mn |
| Jun 30, 2023 | 265.63 Mn |
| Mar 31, 2023 | 263.97 Mn |
| Dec 31, 2022 | 257.09 Mn |
| Sep 30, 2022 | 259.30 Mn |
| Jun 30, 2022 | 253.64 Mn |
| Mar 31, 2022 | 251.89 Mn |
| Dec 31, 2021 | 249.24 Mn |
| Sep 30, 2021 | 249.91 Mn |